and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Alkermes plc Stock Price (Quote) NASDAQ:ALKS
$31.43 ( 2.95% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $26.59 | $31.54 | Tuesday, 5th Jul 2022 ALKS stock ended at $31.43. This is 2.95% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 4.98% from a day low at $30.04 to a day high of $31.54. |
| 90 days | $26.14 | $32.79 | |
| 52 weeks | $21.24 | $33.00 |
Historical Alkermes plc prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $30.17 | $31.54 | $30.04 | $31.43 | 1 369 930 |
| 2022-07-01 | $30.10 | $30.58 | $29.58 | $30.53 | 843 790 |
| 2022-06-30 | $30.11 | $30.52 | $29.64 | $29.79 | 1 165 156 |
| 2022-06-29 | $30.42 | $30.57 | $29.91 | $30.29 | 1 104 416 |
| 2022-06-28 | $29.78 | $30.58 | $29.73 | $30.39 | 1 153 709 |
| 2022-06-27 | $29.89 | $30.14 | $29.57 | $29.77 | 645 893 |
| 2022-06-24 | $29.69 | $30.21 | $29.39 | $29.71 | 2 294 165 |
| 2022-06-23 | $28.19 | $29.70 | $28.15 | $29.56 | 1 305 726 |
| 2022-06-22 | $27.45 | $29.49 | $27.28 | $28.07 | 1 825 114 |
| 2022-06-21 | $28.42 | $28.62 | $27.62 | $27.65 | 1 281 040 |
| 2022-06-17 | $27.31 | $28.86 | $27.31 | $28.03 | 3 254 373 |
| 2022-06-16 | $27.04 | $27.49 | $26.74 | $27.01 | 1 101 716 |
| 2022-06-15 | $27.38 | $27.79 | $26.99 | $27.63 | 753 246 |
| 2022-06-14 | $27.46 | $27.62 | $26.59 | $27.19 | 900 559 |
| 2022-06-13 | $26.82 | $27.36 | $26.60 | $27.34 | 1 155 241 |
| 2022-06-10 | $27.55 | $27.77 | $27.09 | $27.46 | 1 326 968 |
| 2022-06-09 | $29.50 | $29.58 | $28.10 | $28.13 | 757 534 |
| 2022-06-08 | $28.95 | $29.25 | $28.66 | $28.97 | 1 302 922 |
| 2022-06-07 | $28.22 | $29.18 | $27.94 | $28.95 | 2 860 968 |
| 2022-06-06 | $29.64 | $29.64 | $28.10 | $28.34 | 1 757 300 |
| 2022-06-03 | $29.68 | $30.09 | $29.21 | $29.31 | 1 117 450 |
| 2022-06-02 | $30.00 | $30.50 | $28.65 | $29.64 | 721 686 |
| 2022-06-01 | $29.73 | $30.27 | $29.34 | $29.97 | 1 206 704 |
| 2022-05-31 | $30.30 | $30.57 | $29.44 | $29.85 | 1 837 770 |
| 2022-05-27 | $29.50 | $30.78 | $29.23 | $30.54 | 1 892 584 |
| 2022-05-26 | $28.88 | $29.54 | $28.32 | $29.36 | 917 279 |
| 2022-05-25 | $28.37 | $29.49 | $28.20 | $28.85 | 1 372 957 |
| 2022-05-24 | $29.00 | $29.21 | $28.24 | $28.35 | 1 283 643 |
| 2022-05-23 | $30.30 | $30.44 | $29.13 | $29.30 | 1 002 700 |
| 2022-05-20 | $29.79 | $30.60 | $29.10 | $30.00 | 1 853 000 |
| 2022-05-19 | $28.61 | $29.70 | $28.61 | $29.48 | 1 080 630 |
| 2022-05-18 | $29.13 | $29.77 | $28.64 | $28.87 | 1 252 809 |
| 2022-05-17 | $29.22 | $29.86 | $28.75 | $29.69 | 1 367 853 |
| 2022-05-16 | $26.76 | $28.96 | $26.68 | $28.93 | 1 749 956 |
| 2022-05-13 | $26.93 | $27.46 | $26.63 | $26.88 | 2 558 293 |
| 2022-05-12 | $26.30 | $27.36 | $26.14 | $26.57 | 1 544 496 |
| 2022-05-11 | $26.84 | $27.54 | $26.26 | $26.40 | 1 697 777 |
| 2022-05-10 | $27.24 | $27.82 | $26.53 | $26.95 | 2 619 414 |
| 2022-05-09 | $27.16 | $27.63 | $26.33 | $26.60 | 1 763 817 |
| 2022-05-06 | $27.66 | $28.32 | $27.33 | $27.63 | 1 926 942 |
| 2022-05-05 | $28.55 | $28.90 | $27.43 | $27.90 | 3 275 966 |
| 2022-05-04 | $29.03 | $29.24 | $27.81 | $28.95 | 1 475 943 |
| 2022-05-03 | $28.88 | $29.28 | $28.42 | $29.00 | 1 610 866 |
| 2022-05-02 | $28.79 | $29.59 | $28.38 | $28.88 | 1 697 934 |
| 2022-04-29 | $28.41 | $30.45 | $28.33 | $28.85 | 2 082 913 |
| 2022-04-28 | $32.23 | $32.79 | $28.67 | $29.79 | 3 555 182 |
| 2022-04-27 | $30.67 | $31.37 | $29.53 | $30.38 | 4 201 155 |
| 2022-04-26 | $28.19 | $28.74 | $27.02 | $27.14 | 1 592 959 |
| 2022-04-25 | $27.84 | $28.48 | $27.49 | $28.47 | 1 104 804 |
| 2022-04-22 | $29.60 | $29.77 | $28.17 | $28.21 | 852 866 |
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. The companys marketed products include ARISTADA (aripiprazole lauroxil) for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; INVEGA SUSTENN... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
